Identifying subtypes of mild cognitive impairment in Parkinson's disease using cluster analysis

Dana Pourzinal1,2, Ji Hyun J Yang1, Gerard J Byrne1,3

  • 1UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Royal Brisbane and Women's Hospital, Building 71/918, Herston, Brisbane, QLD, 4029, Australia.

Journal of Neurology
|June 15, 2020
PubMed
Abstract

Insights

Researchers identified four distinct cognitive subtypes in Parkinson's disease patients with mild cognitive impairment (PD-MCI), differentiating them by frontal, posterior, or global impairment, or cognitive intactness.

Area of Science:

  • Neuroscience
  • Neurology
  • Cognitive Science

Background:

  • Mild Cognitive Impairment (MCI) in Parkinson's disease (PD) is crucial for identifying dementia risk.
  • Subtyping MCI in PD aids therapeutic development and patient management.
  • Previous studies highlight memory and executive dysfunction in PD.

Purpose of the Study:

  • To explore memory and executive impairment subtypes in non-demented PD patients.
  • To identify associated clinical features within these cognitive subtypes.

Main Methods:

  • K-means cluster analysis on cognitive variables from 85 non-demented PD patients.
  • Validation of cluster structure based on multiple validity measures.
  • Creation of cluster profiles using cognitive and clinical/demographic data.

Main Results:

  • Four distinct cognitive phenotypes were identified: frontal-dominant, posterior-cortical-dominant, global impairment, and cognitively intact.
  • Significant differences observed in age, gender, global cognition, and motor symptoms across clusters.
  • No significant differences found in depression, apathy, or anxiety levels between clusters.

Conclusions:

  • The study validates distinct cognitive phenotypes within PD-MCI.
  • These findings support further research into the clinical progression and neuroimaging of these subtypes.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
842
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
437